View Older Stories

Oct 15, 2025 04:35AM Citizens Reiterates Market Outperform Rating on ProQR Therapeutics N.V. (PRQR)

Oct 8, 2025 04:09AM Citizens Reiterates Market Outperform Rating on Terns Pharmaceuticals (TERN)

Sep 16, 2025 06:10AM Lilly weight-loss pill could be FDA-approved by year-end

Jun 25, 2025 07:47AM Citi bullish on Lilly as Orforglipron unlocks $40B+ obesity market

Jun 25, 2025 05:11AM Citi Reiterates Buy Rating on Eli Lilly (LLY)

Jun 10, 2025 03:25PM Citi on Hims and Hers (HIMS): 'If HIMS does end up partnering with LLY, in our view it would signal that HIMS is “throwing in the towel” on compounded GLP-1s'

Feb 25, 2025 06:48AM Lilly offers weight-loss drugs in vials at a discount to fight competition

Jan 15, 2025 04:54AM Citi Reiterates Buy Rating on Eli Lilly (LLY)

Jan 13, 2025 09:01AM Lilly (LLY) to acquire Scorpion Therapeutics' mutant-selective PI3Kα inhibitor program

Jan 13, 2025 09:00AM Lilly to acquire Scorpion Therapeutics' mutant-selective PI3Kα inhibitor program

Dec 20, 2024 08:43AM Citi Reiterates Buy Rating on Eli Lilly (LLY)

Nov 1, 2024 08:30AM Citi is 'aggressively' buying selloff in this pharma stock

Sep 13, 2024 01:04PM Citi restarts coverage of Eli Lilly with Buy rating on increased tirzepatide forecasts

Sep 13, 2024 03:28AM Citi Resumes Eli Lilly (LLY) at Buy

Sep 3, 2024 04:14PM Eli Lilly partner BioAge files for US IPO

Aug 27, 2024 08:24AM Citi on Hims and Hers (HIMS) Post Lilly (LLY) News: 'Single-dose Zepbound Vials a Shot Across the Bow for the Compounders'

Aug 27, 2024 06:49AM Lilly launches vials of weight-loss drug Zepbound for as low as $399 a month

Aug 21, 2024 10:39AM Selloff in MedTech stocks 'seems overdone': Citi

Aug 16, 2024 08:39AM Lilly (LLY) Completes Acquisition of Morphic

Aug 16, 2024 08:38AM Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease

Jul 8, 2024 06:48AM Eli Lilly & Co. (LLY) to Acquire Morphic (MORF) for $57/sh Cash or $3.2B

Jul 8, 2024 06:45AM Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease

Jun 24, 2024 09:06AM ResMed, Inspire Medical slump after Lilly's positive Zepbound data; Citi downgrades

Apr 30, 2024 10:00AM Eli Lilly (LLY) stock climbs on gross margin beat, raised 2024 revenue outlook

Apr 2, 2024 04:03AM Eli Lilly (LLY) PT Raised to $895 at Citi

Mar 17, 2024 08:00PM Top pharma stocks to own in 2024 – Citi

Dec 19, 2023 08:24AM Citi sees attractive buying opportunity in this beaten-down big pharma stock

Dec 11, 2023 12:16PM Midday movers: Macy’s, Broadcom, Eli Lilly and more

Nov 2, 2023 11:11AM Citi continue to see upside to Eli Lilly & Co.'s (LLY) 'already rich' valuation

Oct 23, 2023 09:36AM Citi hikes Eli Lilly & Co. (LLY) price target on Incretin estimates

Oct 23, 2023 05:55AM Eli Lilly (LLY) PT Raised to $675 at Citi

Aug 7, 2023 08:40AM Dow Jones, Nasdaq, S&P 500 weekly preview: Better than feared Q2 results, worse than expected reactions

Feb 15, 2023 05:49PM Today's most important downgrades

Aug 25, 2022 03:18PM It's Good to Be Eli Lilly (LLY) in 2022 Says Citi Analyst

Aug 25, 2022 10:00AM Lilly to Participate in Citi's 17th Annual BioPharma Conference

Nov 29, 2021 06:45AM 2 Reasons Why Citi Downgraded Merck (MRK) to Neutral Today, Opened a Negative Catalyst Watch

Sep 29, 2021 09:29AM Pre-Open Stock Movers 09/29: (GREE) (AUVI) (LCID) Higher; (LFMD) (LSPD) (EQT) Lower (more...)

Sep 29, 2021 08:46AM Eli Lilly (LLY) Stock Soars As Citi Upgrades to Buy Amid Recent Selloff in Shares

Sep 29, 2021 05:24AM UPDATE: Citi Upgrades Eli Lilly (LLY) to Buy (correction)

Sep 21, 2021 04:15PM Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.5 Billion Combined Aggregate Principal Amount of Its Outstanding Debt Securities

Sep 21, 2021 07:00AM Lilly Announces the Early Tender Results of Its Pending Cash Tender Offer for Up to $1.5 Billion Combined Aggregate Principal Amount of Its Outstanding Debt Securities and Removal of the Note Caps for

Sep 7, 2021 06:09AM Eli Lilly & Co. (LLY) Announces Cash Tender Offer for for Up to $1.5B of its Notes

Sep 7, 2021 06:00AM Lilly Announces Cash Tender Offer for Up to $1.5 Billion Combined Aggregate Principal Amount of Its Outstanding Debt Securities

Aug 31, 2021 02:00PM Lilly to Participate in Citi's 16th Annual BioPharma Virtual Conference

Apr 23, 2020 06:44AM Eli Lilly lifts 2020 profit forecast; coronavirus fuels stockpiling of its medicines

Jan 23, 2020 06:16AM Elanco Animal Health (ELAN) Announces Upsizing and Pricing of Common Stock and Pricing of Tangible Equity Unit Offerings

Jan 23, 2020 06:00AM Elanco Animal Health Announces Upsizing and Pricing of Common Stock and Pricing of Tangible Equity Unit Offerings

Jan 21, 2020 04:37PM Elanco Animal Health (ELAN) Announces Common Stock, Tangible Equity Unit Offerings Associated with Financing Acquisition of Bayer's Animal Health Business

Jan 21, 2020 04:37PM Elanco Animal Health Announces Common Stock and Tangible Equity Unit Offerings Associated with Financing Acquisition of Bayer’s Animal Health Business

Jan 10, 2020 06:30AM Lilly (LLY) Announces Agreement to Acquire Dermira (DERM) for $18.75/Share in $1.1 Billion Deal

View Older Stories